Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.40
Bid: 163.00
Ask: 163.40
Change: -1.00 (-0.61%)
Spread: 0.40 (0.245%)
Open: 161.20
High: 164.40
Low: 161.20
Prev. Close: 164.40
PFD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Rump Placing

8 Apr 2014 09:36

RNS Number : 3106E
Premier Foods plc
08 April 2014
 



THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR NEW ZEALAND AND SHOULD NOT BE DISTRIBUTED IN, FORWARDED TO OR TRANSMITTED IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF LOCAL SECURITIES LAWS OR REGULATIONS. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

8 April 2014

Premier Foods plc

Result of Rump Placing

Premier Foods announces the placing of the Rights Issue Rump

Following the announcement earlier this morning regarding valid acceptances under the fully underwritten Rights Issue announced by Premier Foods plc (the "Company") on 4 March 2014, the Company confirms that Credit Suisse, Jefferies and HSBC, in their capacity as Underwriters, have procured subscribers for the remaining 18,062,657 New Ordinary Shares for which valid acceptances were not received, representing 3.56 per cent. of New Ordinary Shares, at a price of 67 pence per New Ordinary Share.

The net proceeds from the placing of such New Ordinary Shares (after the deduction of the Rights Issue Price of 50 pence per New Ordinary Share and the expenses of procuring subscribers) will be paid to those persons whose rights have lapsed in accordance with the terms of the Rights Issue, pro rata to their lapsed provisional allotments, save that individual amounts of less than £5.00 will not be paid to such persons but will be paid to the Company.

END

Enquiries

Premier Foods plc +44 (0) 1727 815 850

Alastair Murray, Chief Financial OfficerRichard Godden, Head of Investor RelationsRichard Johnson, Group Corporate Affairs Director

Maitland +44 (0) 20 7379 5151

Liz MorleyTom Eckersley

Credit Suisse +44 (0) 20 7888 8888

Ian Carnegie-BrownStuart FieldKaan Kesedar

Jefferies International Limited +44 (0) 20 7029 8000

Paul NichollsNeil CollingridgeLee Morton

HSBC +44 (0) 20 7991 8888

Nick DonaldStuart DicksonJames Horsburgh

IMPORTANT NOTICE

This announcement is an advertisement and not a prospectus. The Prospectus was published on 4 March 2014. Nothing in this announcement should be interpreted as a term or condition of the Placing or the Rights Issue.

Capitalised terms defined in the Prospectus dated 4 March 2014 shall have the same meaning when used in this announcement.

This announcement is for information purposes only and does not constitute or form part of any offer or invitation to purchase, otherwise acquire or subscribe for, sell or otherwise dispose of or issue, or any solicitation of any offer or invitation to purchase, otherwise acquire or subscribe for, sell or otherwise dispose of or issue securities in the United States, Australia, Canada, Japan or New Zealand or any other jurisdiction.

This announcement is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia).

None of the securities referred to in this announcement have been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Company does not intend to register any part of the Placing or the Rights Issue in the United States or to conduct a public offering of securities in the United States. No money, securities or other consideration is being solicited and, if sent in response to the information contained herein, will not be accepted.

None of the securities referred to in this announcement have been, and will not be, registered under the securities laws of any Excluded Territory and may not be offered, sold, taken up, exercised, resold, transferred or delivered, directly or indirectly, within the Excluded Territories except pursuant to an applicable exemption from registration and in compliance with any applicable securities laws.

Each of Credit Suisse, Jefferies, HSBC, BNP Paribas, Barclays, Investec, Shore Capital and Ondra Partners, acted for the Company and no one else in connection with the Placing and the Rights Issue and will not regard any other person as a client in relation to the Placing or the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or the Rights Issue or any matters referred to in this announcement.

Apart from the responsibilities and liabilities, if any, which may be imposed on the each of Credit Suisse, Jefferies, HSBC, BNP Paribas, Barclays, Investec, Shore Capital and Ondra Partners by FSMA or the regulatory regime established thereunder or under US securities laws or other law, each of Credit Suisse, Jefferies, HSBC, BNP Paribas, Barclays, Investec, Shore Capital and Ondra Partners accept no responsibility whatsoever for, nor make any representation or warranty, express or implied, in relation to, the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company, the Placing Shares, the New Ordinary Shares, the Placing, the Rights Issue or any other matter referred to in or otherwise connected with this announcement and nothing in this announcement is, or shall be, relied upon as a promise or representation in this respect, whether as to the past or the future. To the fullest extent permissible, each of Credit Suisse, Jefferies, HSBC, BNP Paribas, Barclays, Investec, Shore Capital and Ondra Partners accordingly disclaim all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which they might otherwise have in respect of this announcement or any such statement. The contents of this announcement are not to be construed as legal, business or tax advice. Each prospective investor should consult his or its own legal adviser, financial adviser or tax adviser for legal, financial or tax advice.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEAPLPEDDLEEF
Date   Source Headline
1st Feb 20231:29 pmRNSDirector/PDMR Shareholding
1st Feb 20239:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSTrading Statement
3rd Jan 20239:00 amRNSTotal Voting Rights
20th Dec 20229:05 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights
24th Nov 202210:46 amRNSDirector Declaration
16th Nov 20227:00 amRNSHalf-year results
8th Nov 20227:00 amRNSNotice of Results
1st Nov 20229:00 amRNSTotal Voting Rights
3rd Oct 202210:00 amRNSBlock listing Interim Review
3rd Oct 20229:00 amRNSTotal Voting Rights
30th Sep 20222:44 pmRNSDirector Declaration
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20222:41 pmRNSCompletion of The Spice Tailor acquisition
25th Aug 20227:00 amRNSDirector/PDMR Shareholding
24th Aug 202210:00 amRNSChange of Auditor
2nd Aug 20229:46 amRNSDirector Declaration
1st Aug 20229:00 amRNSTotal Voting Rights
29th Jul 202210:34 amRNSHolding(s) in Company
25th Jul 20227:00 amRNSAcquisition of The Spice Tailor
20th Jul 20224:07 pmRNSResult of AGM
20th Jul 20227:00 amRNSQ1 Trading Update
1st Jul 20228:30 amRNSTotal Voting Rights
22nd Jun 20223:05 pmRNSDividend Record Date Confirmation
10th Jun 20223:04 pmRNSDirector/PDMR Shareholding
6th Jun 202211:35 amRNSNotice of AGM
1st Jun 20229:00 amRNSTotal Voting Rights
27th May 202211:00 amRNSDirectorate Change
25th May 202212:25 pmRNSHolding(s) in Company
25th May 20227:00 amRNSHolding(s) in Company
19th May 202210:02 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSPreliminary Results
13th May 20222:21 pmRNSRemuneration Committee Chair
3rd May 20229:00 amRNSTotal Voting Rights
27th Apr 202212:14 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSDirectorate Change
21st Apr 20227:00 amRNSNotice of Results
8th Apr 20229:08 amRNSHolding(s) in Company
1st Apr 20228:24 amRNSBlock listing Interim Review
1st Apr 20228:00 amRNSTotal Voting Rights
10th Mar 20221:02 pmRNSNon-Executive Director Appointment
3rd Mar 202212:47 pmRNSDirector/PDMR Shareholding
1st Mar 20229:00 amRNSTotal Voting Rights
25th Feb 20222:29 pmRNSDirector/PDMR Shareholding
9th Feb 20223:17 pmRNSDirector/PDMR Shareholding
8th Feb 20222:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:27 pmRNSDirector/PDMR Shareholding
1st Feb 20223:00 pmRNSDirector/PDMR Shareholding
1st Feb 202211:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.